Latest Updates of 12 Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com
Page 8 - Dtx Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dtx Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dtx Pharma Today - Breaking & Trending Today
DelveInsight Business Research, LLP: DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
RNA interference clinical trial pipeline constitutes 85+ key companies continuously working towards developing 100+ RNA interference therapies, analyzes DelveInsight LAS VEGAS, Nov. 1,
Source: finanznachrichten.de
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
/PRNewswire/ -- DelveInsight's 'RNA Interference Competitive Landscape – 2022' report provides comprehensive global coverage of available, marketed, and...
Source: prnewswire.com
Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
Investegate announcements from INVENTIVA, Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
Source: investegate.co.uk
INVENTIVA: Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
Sino Biopharm a leading Chinese pharmaceutical group, through CTTQ will oversee the development and commercialization of lanifibranor in Greater ChinaLanifibranor is an orally-available small molecule
Source: finanznachrichten.de